U.S. Stem Cell, Inc. (USRM)

U.S. Stem Cell Revenue

In the year 2022, U.S. Stem Cell had annual revenue of $82.05K, down -59.13%. U.S. Stem Cell had revenue of $19.97K in the quarter ending December 31, 2022, a decrease of -15.34%.

• Revenue: 82.05K
• Revenue Growth: -59.13%
• P/S Ratio: 0.01
• Revenue / Employee: 7.46K
• Employees: 11
• Market Cap: 662.00

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	82.05K	-118.70K	-59.13%
Dec 31, 2021	200.75K	-76.34K	-27.55%
Dec 31, 2020	277.09K	-2.80M	-90.98%
Dec 31, 2019	3.07M	-3.63M	-54.15%
Dec 31, 2018	6.70M	1.18M	21.38%